Niraparib for the treatment of metastatic ccRCC in a patient with CDK12 and RAD51C mutations: a case report
BackgroundNiraparib, a poly ADP-ribose polymerase inhibitors (PARPi), has been widely applied in the intervention of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Nevertheless, as of the present moment, there are limited instances demonstrating favorable outcomes stemming from ni...
Bewaard in:
Hoofdauteurs: | , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |